Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Avalon GloboCare | ALBT | 15. nov 2024 | 3.15 | +4.30 |
Avalon Holdings | AWX | 15. nov 2024 | 3.30 | -0.90 |
Avalonbay Communities | AVB | 15. nov 2024 | 229.41 | +0.65 |
Avangrid | AGR | 15. nov 2024 | 35.97 | +0.59 |
Avanos Medical | AVNS | 15. nov 2024 | 18.68 | -2.45 |
Avantor | AVTR | 15. nov 2024 | 20.74 | -1.94 |
Aveanna Healthcare | AVAH | 15. nov 2024 | 5.57 | +1.09 |
Avenue Therapeutics | ATXI | 15. nov 2024 | 1.93 | +2.66 |
AvePoint A | AVPT | 15. nov 2024 | 15.73 | -0.57 |
Avery Dennison | AVY | 15. nov 2024 | 197.73 | -1.09 |
Aviat Networks | AVNW | 15. nov 2024 | 13.79 | -0.86 |
Avid Bioservices | CDMO | 15. nov 2024 | 12.14 | +1.76 |
Avidity Biosciences | RNA | 15. nov 2024 | 42.18 | -15.59 |
AvidXchange | AVDX | 15. nov 2024 | 10.44 | -2.79 |
Avient | AVNT | 15. nov 2024 | 50.64 | -1.00 |
Avinger | AVGR | 15. nov 2024 | 0.79 | -2.47 |
Avino Silver & Gold Mines | ASM | 15. nov 2024 | 1.03 | -7.21 |
Avis Budget Group | CAR | 15. nov 2024 | 100.25 | -5.92 |
Avista | AVA | 15. nov 2024 | 37.75 | +1.51 |
AVITA Medical ADR | RCEL | 15. nov 2024 | 11.95 | -5.01 |
Avnet | AVT | 15. nov 2024 | 53.07 | +0.06 |
Aware | AWRE | 15. nov 2024 | 1.44 | -4.00 |
Axalta Coating Systems | AXTA | 15. nov 2024 | 40.29 | -0.91 |
Axcelis Technologies | ACLS | 15. nov 2024 | 73.22 | -7.14 |
AXIL Brands | AXIL | 15. nov 2024 | 3.88 | -7.30 |
Axis Capital | AXS | 15. nov 2024 | 86.73 | +1.94 |
Axis Capital E Pref | AXS-E | 15. nov 2024 | 22.66 | +0.27 |
Axogen | AXGN | 15. nov 2024 | 12.64 | +1.36 |
Axon Enterprise | AXON | 15. nov 2024 | 599.35 | -0.86 |
Axonics | AXNX | 15. nov 2024 | 70.98 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.